US Patent Issued to NeuroSense Therapeutics on Jan. 20 for "Compositions comprising an anti-inflammatory drug and a dicer activator for use in the treatment of neuronal diseases" (Israeli Inventor)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,768, issued on Jan. 20, was assigned to NeuroSense Therapeutics Ltd. (Herzeliya, Israel).

"Compositions comprising an anti-inflammatory drug and a dicer activator for use in the treatment of neuronal diseases" was invented by Alon Ben-Noon (Ramat-Hasharon, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses compositions, means and kits thereof for treating neuronal clinical indications in a mammalian subject. The composition comprises, inter alia, a synergistic combination of an anti-inflammatory drug and a DICER activator. The present invention further discloses methods for treating neuronal diseases including Moto...